American Vietnamese Biotech (HSTC:AMV) Net Margin % : 0.00% (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. American Vietnamese Biotech's Net Income for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, American Vietnamese Biotech's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for American Vietnamese Biotech's Net Margin % or its related term are showing as below:

HSTC:AMV's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -154.79
* Ranked among companies with meaningful Net Margin % only.

American Vietnamese Biotech Net Margin % Historical Data

The historical data trend for American Vietnamese Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Net Margin % Chart

American Vietnamese Biotech Annual Data

Trend

Net Margin %

American Vietnamese Biotech Quarterly Data

Net Margin %

Competitive Comparison of American Vietnamese Biotech's Net Margin %

For the Biotechnology subindustry, American Vietnamese Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Net Margin % falls into.

American Vietnamese Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

American Vietnamese Biotech's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin	=	Net Income (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

American Vietnamese Biotech's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin	=	Net Income (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

American Vietnamese Biotech (HSTC:AMV) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

American Vietnamese Biotech Net Margin % Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.